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Abstract 
Background 
Protein kinases are involved in relevant physiological functions and a broad number of 
mutations in this superfamily have been reported in the literature to affect protein function 
and stability. Unfortunately, the exploration of the consequences on the phenotypes of each 
individual mutation remains a considerable challenge. 
Results 
The wKinMut web-server offers direct prediction of the potential pathogenicity of the 
mutations from a number of methods, including our recently developed prediction method 
based on the combination of information from a range of diverse sources, including 
physicochemical properties and functional annotations from FireDB and Swissprot and 
kinase-specific characteristics such as the membership to specific kinase groups, the 
annotation with disease-associated GO terms or the occurrence of the mutation in PFAM 
domains, and the relevance of the residues in determining kinase subfamily specificity from 
S3Det. This predictor yields interesting results that compare favourably with other methods 
in the field when applied to protein kinases. 
Together with the predictions, wKinMut offers a number of integrated services for the 
analysis of mutations. These include: the classification of the kinase, information about 
associations of the kinase with other proteins extracted from iHop, the mapping of the 
mutations onto PDB structures, pathogenicity records from a number of databases and the 
classification of mutations in large-scale cancer studies. Importantly, wKinMut is connected 
with the SNP2L system that extracts mentions of mutations directly from the literature, and 
therefore increases the possibilities of finding interesting functional information associated to 
the studied mutations. 
Conclusions 
wKinMut facilitates the exploration of the information available about individual mutations 
by integrating prediction approaches with the automatic extraction of information from the 
literature (text mining) and several state-of-the-art databases. 
wKinMut has been used during the last year for the analysis of the consequences of mutations 
in the context of a number of cancer genome projects, including the recent analysis of 
Chronic Lymphocytic Leukemia cases and is publicly available at 
http://wkinmut.bioinfo.cnio.es. 
Background 
Current high-throughput resequencing screenings [1-3] represent a powerful set of techniques 
to discover large numbers of mutations. Of these, only a small fraction are causally 
implicated in disease onset and therefore, separating the wheat from the chaff is still a major 
challenge [4]. The interpretation of the overwhelming wealth of data also represents an issue 
in other fields, such as protein function prediction [5]. For a small subset of the new 
mutations discovered, experimental information regarding the relationship between the 
mutation and the underlying biochemical mechanism is known. However, there is no 
information for the remaining mutations. The intensive requirement of resources makes it 
unfeasible to experimentally test the association of all these mutations to disease, and to 
characterize their functional effects. Nevertheless, this problem is very amenable to in silico 
predictors [4,6,7]. Different approaches are currently available to predict the probability of a 
newly discovered mutation being implicated in disease. Some methods identify crucial 
positions in a given protein and derive generalized rules to predict the pathogenicity of 
mutations. Other methods assume that evolutionarily conserved protein residues are 
important for protein structure, folding and function, whereby mutations in these residues are 
considered deleterious [8]. Variations on this principle lead to methods that predict 
deleterious mutations by evaluating changes in evolutionarily conserved PFAM motifs [9]. A 
number of systems use protein structures to characterize substitutions that significantly 
destabilize the folded state. There are also methods that integrate prior knowledge in the form 
of both sequence and structure-related features from a set of experimentally characterized 
mutations to train automatic machine-learning systems. These systems can infer the 
pathogenicity of new mutations based on the cases evaluated. Albeit similar in purpose, very 
different machine-learning methods can be implemented. Among them, probably the most 
popular ones are: rule-based systems [10-12], decision trees [13], random forests [14,15], 
neural networks [16,17], Bayesian methods [18] and SVMs [19-23]. Recently, some meta 
approaches that combine different methodologies have been implemented. For example, 
Condel [24] integrates five of the most widely employed computational tools for detecting 
pathogenic single nucleotide variations. Predictors can also be classified according to their 
scope. Most of the predictors are generally applicable to amino acid sequences from any 
protein family, while a few of them include properties that apply only to a given protein 
family of interest; i.e. protein kinase specific predictors [20,23]. These family-related features 
bring discriminative information that justifies the development of specialized predictors. 
A broad number of mutations in the protein kinase superfamily have been reported in the 
literature [25] and a subset of them is known to disrupt protein structure and function [26]. 
For some cases, since human protein kinases are involved in a plethora of physiological 
functions, this disruption can be causally associated to disease [27]. Still, the majority of 
protein kinase mutations are tolerated without apparent significant effects [28,29]. 
In previous publications, we have discussed the preferential distribution of germline 
pathogenic deviations [30] and driver somatic mutations [31] with respect to regions of 
functional and structural importance. Here we present, wKinMut, an integrated web-service 
for the collection of information from multiple sources and for the prediction of the 
pathogenicity of mutations by combining several prediction approaches. The objective of 
wKinMut is to provide a one-stop resource for the analysis and interpretation of the 
consequences of mutations in the protein kinase superfamily. 
Implementation 
wKinMut represents the first resource to provide an integrated tool for the analysis and 
interpretation of the consequences of mutations in the protein kinase superfamily. The main 
objective of wKinMut is to aid computational biologists and clinicians to prioritize 
pathogenic mutations and to understand the mechanisms by which some mutations lead to 
disease, and particularly, to cancer. 
The tool presented here, incorporates information retrieval and prediction approaches and 
displays information from diverse sources. First, it simplifies the collection of information 
about the mutations, such as the classification, domain architecture, functional annotations 
and plausible interaction partners of the kinase. Furthermore, kinase mutations are analyzed 
in their structural context and mentions in dedicated databases, genotyping studies and the 
literature that suggest an implication in disease are also presented. Second, wKinMut 
estimates the theoretical pathogenicity of kinase mutations with three different approaches, 
including our newly developed kinase-specific method, KinMut [23], based on the evaluation 
of a wide set of sequence-derived features that describe each independent mutation. The 
affected domain and kinase group, diverse functional annotations, residue physicochemical 
properties and relevance of the mutated residues in determining subfamily specificity are 
considered. 
wKinMut has been implemented mostly in Ruby. The functionality is implemented as a 
workflow accessible through a REST interface that can render the results either in JSON 
format or HTML. The later constitutes the interface described in this document. Some of data 
resources that support this system, such as gene descriptions or iHOP interactions, are 
queried remotely through the internet as demanded; but are then cached to improve 
subsequent accesses. The server incorporates some additional caching schemes to improve 
performance in the back-end, by persisting the job results, and in the web interface, by 
caching the HTML. 
Web interface 
Step 1: submission of mutations for analysis 
The input to wKinMut are non-synonymous mutations in the protein kinase superfamily. The 
input format should encode the Uniprot/Swissprot accession number, the wild type residue, 
the position and the mutated residue. Non-standard amino acids and truncating mutations will 
be excluded from the analysis. An example of this format would be a mutation from Glycine 
to Alanine in position 719 of the human epidermal growth factor receptor, which is encoded 
as P00533 G719A. In the following sections, we will use this example to guide the reader 
through the different result views (Figure 1). Multiple mutations can be submitted at a time, 
either as a plain text file or directly via the applications form, the sample dataset provided as 
part of wKinMut’s documentation can be used as a formatting guide. 
Figure 1 Summary of the different result pages in wKinMut: Example of a Gly-719-Ala 
mutation in the human epidermal growth factor receptor. The figure shows an example 
of an input to the server (panel a) and the results summary table (panel b). The rest of panels 
display show the different outputs from the server, including the gene/protein summary tab 
(panel c), the domain tab (panel d), the structure view (panel e), the pathogenicity assessment 
(panel f). Information from the databases, the literature and iHop is exemplified in panels g, h 
and i respectively. 
Step 2: interpretation of the consequences of the mutations 
The first output the user will get right after submitting the mutations is a summary page with 
useful information about the requested mutations (Figure 1, panel b). It includes a description 
of the proteins in Uniprot, the membership to kinase groups in the classification in KinBase 
[32,33] and the estimation of the pathogenicity of mutations attending to our kinase-specific 
predictor of pathogenicity, KinMut [23]. The prediction of the pathogenicity will be 
discussed in detail in a forthcoming section, nevertheless we decided to include this 
information at this step as a guide to prioritize mutations. It might be interesting to point out 
here that users interested only in the results from KinMut, can find a link to the predictions in 
this summary page that can be accessed programmatically. The scope of wKinMut goes 
beyond providing raw prediction of pathogenicity from KinMut, the web-service’s main goal 
is to aid computational biologists and clinicians to understand and to interpret the 
consequences of kinase mutations. Hence, information complementary to KinMut 
predictions, is provided. In the summary table, the ‘View’ link in the right-most ‘Details’ 
column (Figure 1, panel b) will redirect the user to another page containing this 
complementary information, which includes: the values of the features used for classification, 
PFAM domains affected by the mutation, protein-protein interaction information extracted 
from the literature with iHop [34], mentions of the mutations in the literature automatically 
mined with SNP2L [25,35], and existing records of the mutations in other dedicated 
databases. This additional information is intended to provide the basic background to help to 
understand and interpret the consequences of the mutations. Each individual piece of 
information will be discussed thoroughly in the following sections. 
General information about the protein/gene 
Information under the ‘gene/protein’ tab (Figure 1, panel c) focuses on information shared by 
all mutations in the same kinase. Background information such as the gene name, the formal 
description in Uniprot and the classification in KinBase [32,33] of the kinase is provided. In 
addition, the system provides the Gene Ontology terms with which the kinase has been 
annotated in each of the independent sub-ontologies (namely Molecular Function, Cellular 
Compartment and Biological Process). This information provides clues to unveil the function 
of the kinase and it is used by KinMut to calculate the likeness of the protein (and 
subsequently the mutation) to play a role in disease. 
PFAM domains 
In a previous publication [23] we demonstrated that mutations occurring in certain domains 
such as the Tyrosine kinase domain (PKinase Tyr, according to PFAM) are more likely to 
cause disease. This is coherent with the assumption that the function of some domains is 
more important than the function of others. In wKinMut, this information is contained in the 
‘PFAM domains’ tab (Figure 1, panel d), which displays the domain (or domains, in some 
cases) where the mutation is occurring and the alignment used by PFAM as seed to generate 
the domain family. The alignment is evaluated in terms of sequence conservation. Under the 
assumption that conserved regions have been preserved by evolution, this information can 
help the user to identify important regions in the structure of the domain. 
Mapping the mutations onto structures 
To understand the consequences of mutations might have in protein stability and function it is 
sometimes useful to study the mutations in their structural contexts. However, mapping 
mutations from sequences to structures is not always trivial [36]. Under the ‘Structures‘ tab, 
wKinMut enables the visualization of the mutation mapped to all available structures. (Figure 
1, panel e). In addition, the versatility of the Jmol applet implemented in wKinMut allows 
advanced users to adapt the visualization to their specific needs. 
Prediction of the pathogenicity 
In wKinMut the theoretical pathogenicity of mutations is assessed by two independent 
methods, namely SIFT [8] and KinMut [23]. This information is displayed in the 
‘Pathogenicity’ tab (Figure 1, panel f). SIFT [8] predicts whether non-synonymous mutations 
are prone to affect protein function. This prediction is based on the degree of conservation of 
the residues in sequence alignments derived from closely related sequences. A threshold 
value of 0.05 is used to determine that mutations are likely to be pathogenic. KinMut [23] is a 
kinase-specific predictor of the pathogenicity of mutations. It relies in a machine-learning 
approach (SVM) to evaluate a number of sequence-derived features that describe kinase 
mutations from different perspectives, including: a) at the gene level, the membership to a 
Kinbase group and Gene Ontology terms. b) at the domain level, the occurrence of the 
mutation inside a PFAM domain, and c) at the residue level, several properties including 
amino acid type, functional annotations from Swissprot and FireDB [37], specificity-
determining positions, etc. SVM scores greater than -0.5 indicate that the mutation is very 
likely pathogenic. The values of these features are also displayed in this section of the web-
service to aid to interpret the predictions. Please, refer to the original publications for 
information on the individual characteristics, capabilities and validation of each predictor. 
Mutations in databases 
The wealth of knowledge provided by current research is usually stored in databases. A 
number of them store information about mutations from diverse perspectives. In wKinMut 
(Figure 1, panel g) we collect information from four different sources (namely the Uniprot 
Variant Pages [38], KinMutBase [39], SAAPdb [26] and COSMIC [40]) in an attempt to 
cover all aspects of protein kinase mutation. The information displayed includes information 
about the structural consequences of mutations, experiments associating mutations with a 
certain disease, or the proof that a mutation has been observed in a cancer sample. 
Automatic extraction of mutations from the literature 
Unfortunately, the databases referred in the previous section do not contain all current 
knowledge about mutations. Even in the cases where a database record exists, the 
knowledgebase cannot always store all contextual information. The context is sometimes 
very important for the correct interpretation of the predictions: experimental conditions, 
patients’ habits and clinical histories, etcetera. wKinMut provides pointers to mentions of the 
mutations in the literature under the ‘Literature’ tab (Figure 1, panel h). We extract this 
information automatically using our in-house text mining approach,SNP2L [25]. In brief, 
SNP2L is a literature mining pipeline for the automatic extraction and disambiguation of 
singlepoint mutation mentions from both abstracts as well as full text articles, followed by a 
sequence validation check to link mutations to their corresponding kinase protein sequences. 
Automatic determination of interaction partners 
wKinMut integrates Protein-Protein Interactions (PPI) gathered from iHOP in the 
homonymous tab (Figure 1, panel i). Briefly, iHOP is a powerful text mining system to 
automatically extract protein protein interactions from PubMed abstracts. To relate the 
interaction information with its context, the sentences including the interaction mentions are 
also provided. 
Conclusion 
wKinMut facilitates the exploration of the information available about individual mutations 
by integrating prediction approaches with the automatic extraction of information from the 
literature (text mining) and several currently available databases. wKinMut works as an open 
accessible web server. 
The system offers direct prediction of the potential pathogenicity of the mutations from a 
number of methods, including our recently developed prediction method based on the 
combination of information from a range of diverse sources with a machine learning system 
[23]. The features used by our new prediction system include: general physicochemical 
properties, annotations of known functional sites from FireDB and Swissprot and kinase-
specific characteristics such as membership to a specific group of kinases, annotations of 
disease associations extracted from GO terms and mapping of PFAM domains, and relevance 
of the residues for the differences between groups of kinases. In addition to the predictions, 
wKinMut offers a number of integrated complementary services that help to understand the 
consequences and the mechanism of the mutations. These services include the classification 
of the kinase, information about associations of the kinase with other proteins extracted 
directly extracted from the Medline abstracts, the mutations on the corresponding protein 
structures, and possible relations with pathogenicity recorded in disease-variation databases 
and from large-scale cancer studies. An important component of wKinMut is the access to 
information about the mutations extracted directly from the literature. This information is 
important for the contextualization of the consequences of the mutations. wKinMut uses our 
previously developed SNP2L [25], that has been shown to provide a substantial addition to 
the information provided by public databases and repositories.. 
In summary, we think that wKinMut constitutes a powerful one-stop shop for the study of the 
potential pathogenic potential of mutations in protein kinases. As such, wKinMut will be of 
interest for bioinformaticians and computational biologists that can use the information 
provided by the server programmatically as part of their own analysis pipelines, and it can be 
also useful to biologists and clinicians who can browse and explore punctual information 
easily from the provided interface. We have used wKinMut during the past year for the 
analysis of the consequences of mutations in the context of a number of personalized cancer 
genome projects (see [41]), including the recent analysis of Chronic Lymphocytic Leukemia 
cases [42,43]. 
A further development of the presented system would consider the analysis of the 
downstream consequences of mutations in relation to potential and known post-translational 
modifications and their interelations (see [44,45]). We are interested in extending wKinMut 
capabilities to the analysis of the combined effect of mutations in pathways and signalling 
networks in where kinases are essential components wKinMut is publicly available at 
http://wkinmut.bioinfo.cnio.es 
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